FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileCryosite Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CTE.AX
Cryosite Limited Stock AnalysisComprehensive stock analysis for Cryosite Limited (CTE.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCTE.AX
CTE.AX
Cryosite Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CTE.AX
  1. Home
  2. Stocks
  3. Cryosite Limited

Cryosite Limited

🇦🇺CTE.AX•ASX

Cryosite Limited

🇦🇺CTE.AX•ASX
P/E ratio
26.64

Your view on CTE.AX

P/E
26.64
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Cryosite Limited

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Jane Hao
Headquarters
13a Ferndell Street, South Granville, NSW, AU
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Jane Hao
Headquarters
13a Ferndell Street, South Granville, NSW, AU
Description

Cryosite Limited, founded in 1999 and headquartered in South Granville, Australia, specializes in providing outsourced logistics and storage solutions to the life sciences industry within Australia. The company operates through two distinct divisions.

Its Clinical Trials and Biological Services Logistics segment offers comprehensive support to the clinical research and pharmaceutical sectors, encompassing services such as specialized temperature-controlled and general biological storage, precise labeling, secondary packaging, and end-to-end supply chain management capabilities like scheduled drug distribution, returns processing, material destruction, status oversight, comparator sourcing, and validated import/export and transportation.

The second division, Cord Blood and Tissues Storage, focuses on the long-term cryogenic preservation of cord blood and tissue samples. Cryosite's client base spans the research, medical, pharmaceutical, veterinary, and biotechnology industries.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Cryosite Limited. Starting points for Cryosite Limited: P/E 26.6, EPS AUD 0.05, beta 0.16 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Cryosite Limited. Cryosite Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Cryosite Limited. Trailing twelve-month EPS for Cryosite Limited stands at AUD 0.05. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis quarterDec 2026Next quarterJun 2027This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 0.03AUD 0.03AUD 0.05AUD 0.06
Lowest estimateAUD 0.03AUD 0.03AUD 0.05AUD 0.06
Highest estimateAUD 0.03AUD 0.03AUD 0.05AUD 0.06
Number of analysts1111
A year ago————
Growth vs a year ago————

Revenue estimates

TotalThis quarterDec 2026Next quarterJun 2027This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 9.20MAUD 9.60MAUD 18.80MAUD 20.20M
Lowest estimateAUD 9.20MAUD 9.60MAUD 18.80MAUD 20.20M
Highest estimateAUD 9.20MAUD 9.60MAUD 18.80MAUD 20.20M
Number of analysts1111
A year ago————
Growth vs a year ago————

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Cryosite Limited. Cryosite Limited has reported as a listed company since 2002. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold CTE.AX20 companies
Compare CTE.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
BDX.AXBCAL Diagnostics LimitedHealthcareMedical - Diagnostics & Research—
CMP.AXCompumedics LimitedHealthcareMedical - Devices—
GSS.AXGenetic Signatures LimitedHealthcareMedical - Diagnostics & Research—
IBX.AXImagion Biosystems LimitedHealthcareMedical - Diagnostics & Research—
IDX.AXIntegral Diagnostics LimitedHealthcareMedical - Diagnostics & Research—
IIQ.AXINOVIQ LtdHealthcareMedical - Diagnostics & Research—
MAP.AXMicroba Life Sciences LimitedHealthcareMedical - Diagnostics & Research—
NUZ.AXNeurizon Therapeutics LimitedHealthcareBiotechnology—
More Medical - Diagnostics & Research companies
TickerTypeCompanySectorExchangeMkt cap
ILMNIllumina, Inc.HealthcareNASDAQ$31.8B
IMDXInsight Molecular Diagnostics Inc.HealthcareNASDAQ$52.1M
IME.AXImExHS LimitedHealthcareASX—
IMMVFImmunovia AB (publ)HealthcareOTC$6.1M
IQVIQVIA Holdings Inc.HealthcareNYSE$42.5B
ISPCiSpecimen Inc.HealthcareNASDAQ$1.3M
IVROInVitro InternationalHealthcareOTC$1.8M
IZO.CNIzotropic CorporationHealthcareCNQ$20.6M
IZOZFIzotropic CorporationHealthcareOTC$11.9M
JMPHFLeveljump Healthcare Corp.HealthcareOTC$15.2M
LDDDLongduoduo Company LimitedHealthcareOTC$15.3M
LHLabcorp Holdings Inc.HealthcareNYSE$30.1B
Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Cryosite Limited. Coverage tracks Cryosite Limited within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Cryosite Limited.

CTE.AX AnalysisGood
Past
2
Growth
4
Health
3
Profit
5
Value
1